Perhaps not so many people know that Markit listed on the market last year as I last reviewed here. Six months ago I opined that:
'So what price the above profile? US$4.8bn or around a x16 forward (FY15e) ebitda profile. I would still say that is fairly full but no disaster for a company targeting 5-7% organic growth in a slow(er) growth world. Below a US$22 share price (or c. 10%+ down from here) the company trades nearer a x16 EV/ebit profile. That's the first price that I will take a look.
Good company and I like their products...but I am going to wait for the share to come to me for the time being'.
Since then the stock has...traded in a pretty tight range between US$25-27.
So what to think then at prevailing? Well the headline results show sales and ebitda growth but margins edge down and earnings are clearly down year-on-year (blamed on 'an increase in depreciation and amortization charges and
higher tax charges compared to Q1 2014'). Pricing was approximately flat on average on their products:
The two largest and most important divisions exhibit deviating performance trends too. The core Information division is pushing along quite nicely...
...but the trade Processing arm was hit by a combination of foreign exchange and the declines in primary issuance volumes:
The capital allocation caught my eye too with a solid level of share buybacks (up to 2.5%+ of the current market cap) and the announcement of a US$500m further buyback over the next two years. Not too shabby off the current US$4.8bn market cap at all.
So some good and some not so compelling especially with a forward P/E of x17s.
There is much to like at Markit as a share to own but for me risk and reward is better balanced at a lower price even with the high recurring (in some form) proportion of revenues. The US$22s still seem more compelling to me. So for now I will continue to be a consumer of their (free) economic information services and await an opportunity to buy the shares.






No comments:
Post a Comment